We are live on ! Find out more
GC

Globeflex Capital Portfolio holdings

AUM $661M
1-Year Est. Return 50.59%
This Fund
S&P 500
This Quarter Est. Return
+3.96%
1 Year Est. Return
+50.59%
3 Year Est. Return
+135.47%
5 Year Est. Return
+202.82%
10 Year Est. Return
+1,069.65%
AUM
$1.18B
AUM Growth
+$135M
Cap. Flow
+$141M
Cap. Flow %
11.99%
Top 10 Hldgs %
28.51%
Holding
522
New
58
Increased
52
Reduced
58
Closed
93

Top Buys

Rank Stock Value
1
BMY icon
Bristol-Myers Squibb
BMY
+$33.6M
2
GOOG icon
Alphabet (Google) Class C
GOOG
+$32.7M
3
V icon
Visa
V
+$30.2M
4
EXEL icon
Exelixis
EXEL
+$21.2M
5
TT icon
Trane Technologies
TT
+$20.6M

Top Sells

Rank Stock Value
1
HOLX
Hologic
HOLX
+$6.85M
2
CCEP icon
Coca-Cola Europacific Partners
CCEP
+$6.7M
3
ARW icon
Arrow Electronics
ARW
+$6.63M
4
YPF icon
YPF
YPF
+$6.31M
5
SNPS icon
Synopsys
SNPS
+$6.28M

Sector Composition

Rank Sector Weight
1 Technology 23.9%
2 Healthcare 21.38%
3 Financials 15.14%
4 Consumer Discretionary 14.1%
5 Industrials 12.64%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
LPLA icon
276
LPL Financial
LPLA
$28.3B
$464K 0.04%
1,420
-3,368
-70% -$996K
JBSS icon
277
John B. Sanfilippo & Son
JBSS
$967M
$464K 0.04%
5,321
– –
CARG icon
278
CarGurus
CARG
$3.27B
$458K 0.04%
12,523
+10,590
+548% +$364K
WTS icon
279
Watts Water Technologies
WTS
$11.5B
$451K 0.04%
2,219
– –
CBT icon
280
Cabot Corp
CBT
$4.54B
$442K 0.04%
4,841
– –
CAH icon
281
Cardinal Health
CAH
$53.9B
$438K 0.04%
3,700
– –
CMCL icon
282
Caledonia Mining Corp
CMCL
$355M
$436K 0.04%
+46,289
New +$592K
XERS icon
283
Xeris Biopharma Holdings
XERS
$1.39B
$424K 0.04%
+125,210
New +$403K
ZM icon
284
Zoom
ZM
$28.2B
$419K 0.04%
5,130
– –
LDOS icon
285
Leidos
LDOS
$14.5B
$418K 0.04%
2,900
+900
+45% +$150K
ILMN icon
286
Illumina
ILMN
$31B
$406K 0.03%
3,041
– –
FHI icon
287
Federated Hermes
FHI
$4.55B
$399K 0.03%
+9,700
New +$392K
RLJ icon
288
RLJ Lodging Trust
RLJ
$1.86B
$392K 0.03%
+38,382
New +$373K
UTMD icon
289
Utah Medical Products
UTMD
$225M
$389K 0.03%
6,336
– –
MYPS icon
290
PLAYSTUDIOS Inc
MYPS
$77.9M
$384K 0.03%
206,444
– –
CMT icon
291
Core Molding Technologies
CMT
$202M
$372K 0.03%
22,466
– –
VCYT icon
292
Veracyte
VCYT
$3.7B
$368K 0.03%
9,304
– –
ATAT icon
293
Atour Lifestyle Holdings
ATAT
$4.67B
$368K 0.03%
13,696
– –
ADSK icon
294
Autodesk
ADSK
$49.5B
$368K 0.03%
1,245
-14
-1% -$4.14K
ARAY icon
295
Accuray
ARAY
$32M
$364K 0.03%
183,771
– –
ABM icon
296
ABM Industries
ABM
$2.81B
$363K 0.03%
7,100
– –
QTWO icon
297
Q2 Holdings
QTWO
$3.8B
$358K 0.03%
3,557
– –
REZI icon
298
Resideo Technologies
REZI
$5.19B
$354K 0.03%
15,350
-1,750
-10% -$41K
CTSH icon
299
Cognizant
CTSH
$24.9B
$331K 0.03%
4,300
– –
AMGN icon
300
Amgen
AMGN
$208B
$322K 0.03%
1,235
– –
10 11
12
13 14

Similar funds

RCG
Regatta Capital Group El Segundo, California $661M AUM 17.85% 1-Year Est. Return
FM
Freemont Management Vaud, Switzerland $661M AUM 60.48% 1-Year Est. Return
ACM
Arosa Capital Management Miami Beach, Florida $660M AUM 210.26% 1-Year Est. Return
UCMOK
United Capital Management of KS Salina, Kansas $660M AUM 50.85% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $661M AUM 299.97% 1-Year Est. Return
FAM
Fulcrum Asset Management London, United Kingdom $662M AUM 48.09% 1-Year Est. Return
CAM
Chandler Asset Management San Diego, California $659M AUM 11.68% 1-Year Est. Return
AWA
Artemis Wealth Advisors New York $662M AUM 39.67% 1-Year Est. Return

Globeflex Capital's Q4 2024 Portfolio in Review

As of Q4 2024, Globeflex Capital held 522 positions worth $1.18B, up 13% from $1.04B the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Globeflex Capital deployed $141M of net new capital in Q4 2024, opening 58 new positions and adding to 52 existing holdings. Its largest new stake was Bristol-Myers Squibb: 602,224 shares worth $34.1M.

By sector, the portfolio is most concentrated in Technology at 24% of assets, down from 25% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Arrow Electronics, an estimated $6.63M trimmed.

  • Globeflex Capital's largest Q4 2024 buy was Bristol-Myers Squibb: 602,224 shares worth $34.1M.
  • Globeflex Capital added most to Alphabet (Google) Class C in Q4 2024, an estimated $32.7M increase.
  • Globeflex Capital's biggest Q4 2024 reduction was Arrow Electronics, cutting an estimated $6.63M.
  • Globeflex Capital fully exited Hologic in Q4 2024, selling an estimated $6.85M.
  • Globeflex Capital's ten largest holdings make up 29% of its $1.18B portfolio in Q4 2024.
  • Globeflex Capital opened 58 new positions and closed 93 in Q4 2024.
  • Globeflex Capital's portfolio value rose 13% quarter-over-quarter to $1.18B.

Based on Globeflex Capital's 13F filing for Q4 2024, filed 10 Feb 2025.